DK0548234T3 - Kloning af kyllingeanæmivirus DNA - Google Patents

Kloning af kyllingeanæmivirus DNA

Info

Publication number
DK0548234T3
DK0548234T3 DK91917088T DK91917088T DK0548234T3 DK 0548234 T3 DK0548234 T3 DK 0548234T3 DK 91917088 T DK91917088 T DK 91917088T DK 91917088 T DK91917088 T DK 91917088T DK 0548234 T3 DK0548234 T3 DK 0548234T3
Authority
DK
Denmark
Prior art keywords
cloning
cav
virus dna
anemia virus
chicken anemia
Prior art date
Application number
DK91917088T
Other languages
English (en)
Inventor
Mathieu Hubertus Maria Noteborn
Gerben Foppe De Boer
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of DK0548234T3 publication Critical patent/DK0548234T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
DK91917088T 1990-09-12 1991-09-11 Kloning af kyllingeanæmivirus DNA DK0548234T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.
PCT/NL1991/000165 WO1992004446A1 (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia dna

Publications (1)

Publication Number Publication Date
DK0548234T3 true DK0548234T3 (da) 2000-06-19

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91917088T DK0548234T3 (da) 1990-09-12 1991-09-11 Kloning af kyllingeanæmivirus DNA

Country Status (21)

Country Link
US (6) US5491073A (da)
EP (2) EP0548234B1 (da)
JP (1) JP2846116B2 (da)
AT (1) ATE188739T1 (da)
AU (1) AU651999B2 (da)
CA (1) CA2091181C (da)
DE (1) DE69131903T2 (da)
DK (1) DK0548234T3 (da)
ES (1) ES2144399T3 (da)
GR (1) GR3033173T3 (da)
HR (1) HRP940668B1 (da)
HU (1) HU220102B (da)
IL (1) IL99435A (da)
MX (1) MX9101042A (da)
NL (1) NL9002008A (da)
RU (1) RU2146292C1 (da)
SI (1) SI9111508B (da)
UA (1) UA48936C2 (da)
WO (1) WO1992004446A1 (da)
YU (1) YU49095B (da)
ZA (1) ZA917065B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922600A (en) * 1990-09-12 1999-07-13 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
AU720640B2 (en) * 1995-06-07 2000-06-08 Leadd B.V. Neutralizing conformational epitopes of chicken anemia virus
US6127115A (en) * 1995-11-14 2000-10-03 Ragland; William L. Efficient method of detecting an infectious agent in blood
ATE283478T1 (de) 1997-08-12 2004-12-15 Leadd Bv Verfahren und vorrichtung zur bestimmung des transformationspotentials von verbindungen.
EP1064024A4 (en) * 1998-03-13 2005-04-06 Univ Georgia Res Found VACCINES AGAINST CIRCOVIRUS INFECTIONS
EA005933B1 (ru) * 1999-09-02 2005-08-25 Леадд Б.В. Апоптин-ассоциированный белок
CA2393859A1 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
ES2364482T3 (es) * 2000-07-10 2011-09-05 Uni-Charm Corporation Artículo de limpieza.
EP1199363A1 (en) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylation modifications of apoptin
US20050169939A1 (en) * 2001-09-05 2005-08-04 Leonard Joan D. Chicken anemia virus vaccine from cell line
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (zh) * 2012-05-15 2012-08-15 扬州大学 快速检测禽白血病抗原的试纸条及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS6032714A (ja) 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
EP0188040B1 (en) 1985-01-11 1991-08-14 Abbott Laboratories Limited Slow release solid preparation
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
EP0434721B1 (en) * 1988-09-13 2000-03-15 Merial Viral nucleotide sequences
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Also Published As

Publication number Publication date
ATE188739T1 (de) 2000-01-15
US6319693B1 (en) 2001-11-20
US6238669B1 (en) 2001-05-29
HRP940668A2 (en) 1997-12-31
JP2846116B2 (ja) 1999-01-13
US5491073A (en) 1996-02-13
EP0548234A1 (en) 1993-06-30
HRP940668B1 (en) 2000-10-31
US5958424A (en) 1999-09-28
DE69131903D1 (de) 2000-02-17
UA48936C2 (uk) 2002-09-16
EP0905246A1 (en) 1999-03-31
YU150891A (sh) 1995-10-24
CA2091181C (en) 2006-02-21
NL9002008A (nl) 1992-04-01
HUT65974A (en) 1994-08-29
IL99435A (en) 2006-10-31
ES2144399T3 (es) 2000-06-16
EP0548234B1 (en) 2000-01-12
US5932476A (en) 1999-08-03
ZA917065B (en) 1992-05-27
HU220102B (hu) 2001-10-28
DE69131903T2 (de) 2000-07-20
SI9111508B (en) 2001-12-31
CA2091181A1 (en) 1992-03-13
GR3033173T3 (en) 2000-08-31
JPH06504195A (ja) 1994-05-19
AU8658091A (en) 1992-03-30
HU9300716D0 (en) 1993-06-28
MX9101042A (es) 1992-08-10
AU651999B2 (en) 1994-08-11
RU2146292C1 (ru) 2000-03-10
US6509446B2 (en) 2003-01-21
IL99435A0 (en) 1992-08-18
US20020103336A1 (en) 2002-08-01
YU49095B (sh) 2003-12-31
SI9111508A (sl) 1998-10-31
WO1992004446A1 (en) 1992-03-19

Similar Documents

Publication Publication Date Title
DK0548234T3 (da) Kloning af kyllingeanæmivirus DNA
ATE329616T1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
ATE214095T1 (de) Verwendung einer exo-nukleotidprobe in der genklonierung
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ATE61632T1 (de) Rna-transformationsvektor.
FI102768B1 (fi) Hybridi-DNA-molekyyli ja menetelmä fibronektiiniä sitovan proteiinin valmistamiseksi
CH0229046H1 (de) Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
ATE141946T1 (de) Hiv-2-virusvarianten
RU93005170A (ru) Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
ATE142700T1 (de) Genetische manipulationen mit von rna-viren abgeleiteten sequenzen enthaltendem rekombinantem dna
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
FI885504A (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
DK0771213T3 (da) Haemophilus influenza adhærens- og penetrationsproteiner
FI905660A0 (fi) Nya polypeptider, dna-sekvenser som moejliggoer deras expression, foerfarande foer framstaellning och anvaendning.
DK498387A (da) Virus-dna-sekvens
AU8405798A (en) A swine hepatitis e virus and uses thereof
ATE99331T1 (de) Fusionsproteine und herstellung davon.
DE69534945D1 (de) Impfstoff für die infektiöse peritonitis der katzen
FI885023A (fi) Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu